Clinical Trials Directory

Trials / Completed

CompletedNCT00610402

Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)

Status
Completed
Phase
Study type
Observational
Enrollment
57 (actual)
Sponsor
University of California, Irvine · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Sturge-Weber Syndrome (SWS) is a neurological disorder characterized at birth by seizures and a large port-wine stain birthmark on the forehead and upper eyelid of one side of the face. SWS is also accompanied by an increased pressure within the eye (glaucoma) which can develop very early in life. Glaucoma represents a group of ocular disorders that are characterized by the loss of retinal ganglion cells and their axons, damage to the optic nerve, and gradual loss of visual field. Recently, several studies provided evidence that there is a potential role of the immune system in the pathogenesis of glaucoma. These findings suggest that there might be changes in systemic humoral immunity possibly underlying the optic neuropathy in at least some glaucoma patients.

Detailed description

The ocular antibody profile in patients with SWS is unknown.The researchers want to study on blood and tear drop samples from patients with SWS to determine the incidence of ocular antibodies in patients with this syndrome.

Conditions

Interventions

TypeNameDescription
OTHERblood sample tear drop sampleblood sample tear drop sample

Timeline

Start date
2007-07-01
Primary completion
2007-07-01
Completion
2008-06-01
First posted
2008-02-08
Last updated
2022-10-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00610402. Inclusion in this directory is not an endorsement.